Myriad Genetics Inc. (MYGN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Myriad Genetics Inc., updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$6.63
+5.41% today
Market cap
$602M
Overall quality
—
Kronos AI 30-day
−32.1%
0 of 8 simulated paths end higher
Myriad Genetics Inc. (MYGN) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $602M. It trades at $6.63, up 5.41% today. 5 analysts' average target of $3.83 implies −42.2% from today's price. Kronos AI's 30-day forecast is −32.1% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.83 |
| Low – high | $2.00 – $8.00 |
| Analysts | 5 |
| Upside to average | −42.2% |
Kronos AI 30-day forecast
| Expected close | $4.27 (−32.1%) |
| Likely range | −36.1% … −28.4% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.